Related references
Note: Only part of the references are listed.Detection approaches for multidrug resistance genes of leukemia
Ying Du et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Reversal of ABCB1 mediated efflux by imatinib and nilotinib in cells expressing various transporter levels
Petr Mlejnek et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2017)
Application of fluorescent dye substrates for functional characterization of ABC multidrug transporters at a single cell level
Zsuzsanna Nerada et al.
CYTOMETRY PART A (2016)
Substrate-specific effects of pirinixic acid derivatives on ABCB1-mediated drug transport
Martin Michaelis et al.
ONCOTARGET (2016)
Tariquidar Is an Inhibitor and Not a Substrate of Human and Mouse P-glycoprotein
Lora D. Weidner et al.
DRUG METABOLISM AND DISPOSITION (2016)
The expression of P-gp in leukemia cells is associated with cross-resistance to protein N-glycosylation inhibitor tunicamycin
Lucia Pavlikova et al.
GENERAL PHYSIOLOGY AND BIOPHYSICS (2016)
Modulation of P-glycoprotein efflux pump: induction and activation as a therapeutic strategy
Renata Silva et al.
PHARMACOLOGY & THERAPEUTICS (2015)
Sensitization of U937 leukemia cells to doxorubicin by the MG132 proteasome inhibitor induces an increase in apoptosis by suppressing NF-kappa B and mitochondrial membrane potential loss
Pablo Cesar Ortiz-Lazareno et al.
CANCER CELL INTERNATIONAL (2014)
Resistance to daunorubicin, imatinib, or nilotinib depends on expression levels of ABCB1 and ABCG2 in human leukemia cells
Petr Kosztyu et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Effect of 9-cis retinoic acid and all-trans retinoic acid in combination with verapamil on P-glycoprotein expression in L1210 cells
A. Breier et al.
NEOPLASMA (2014)
Fluorescent substrates for flow cytometric evaluation of efflux inhibition in ABCB1, ABCC1, and ABCG2 transporters
J. Jacob Strouse et al.
ANALYTICAL BIOCHEMISTRY (2013)
New Insight into P-Glycoprotein as a Drug Target
Albert Breier et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2013)
Can P-glycoprotein mediate resistance to nilotinib in human leukaemia cells?
Petr Kosztyu et al.
PHARMACOLOGICAL RESEARCH (2013)
P-Glycoprotein-Activity Measurements in Multidrug Resistant Cell Lines: Single-Cell versus Single-Well Population Fluorescence Methods
Jennifer Pasquier et al.
BIOMED RESEARCH INTERNATIONAL (2013)
P-glycoprotein depresses cisplatin sensitivity in L1210 cells by inhibiting cisplatin-induced caspase-3 activation
Lenka Gibalova et al.
TOXICOLOGY IN VITRO (2012)
The Specific P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)
Pavitra Kannan et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Advances in the Molecular Detection of ABC Transporters Involved in Multidrug Resistance in Cancer
Jean-Pierre Gillet et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2011)
Cytometric Assessment of Mitochondria Using Fluorescent Probes
Cecile Cottet-Rousselle et al.
CYTOMETRY PART A (2011)
Tunicamycin Depresses P-Glycoprotein Glycosylation Without an Effect on Its Membrane Localization and Drug Efflux Activity in L1210 Cells
Mario Seres et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
Ratiometric high-resolution imaging of JC-1 fluorescence reveals the subcellular heterogeneity of astrocytic mitochondria
Vera C. Keil et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2011)
Calcein assay: a high-throughput method to assess P-gp inhibition
H. Glavinas et al.
XENOBIOTICA (2011)
Mitochondria and Energetic Depression in Cell Pathophysiology
Enn Seppet et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2009)
ABC multidrug transporters: structure, function and role in chemoresistance
Frances J. Sharom
PHARMACOGENOMICS (2008)
Does the calcein-AM method assay the total cellular 'labile iron pool' or only a fraction of it?
Margarita Tenopoulou et al.
BIOCHEMICAL JOURNAL (2007)
Tariquidar (XR9576): a P-glycoprotein drug efflux pump inhibitor
Elizabeth Fox et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2007)
L1210 cells cultivated under the selection pressure of doxorubicin or vincristine express common mechanisms of multidrug resistance based on the overexpression of P-glycoprotein
Viera Bohacova et al.
TOXICOLOGY IN VITRO (2006)
JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells
D Chaoui et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2006)
Expression of P-glycoprotein in L1210 cells is linked with rise in sensitivity to Ca2+
Z Sulová et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
P-glycoprotein - Implications of metabolism of neoplastic cells and cancer therapy
A Breier et al.
CURRENT CANCER DRUG TARGETS (2005)
Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia
K Swerts et al.
LEUKEMIA & LYMPHOMA (2004)
Mitotracker Green is a P-glycoprotein substrate
LF Marques-Santos et al.
BIOSCIENCE REPORTS (2003)
Classification analysis of P-glycoprotein substrate specificity
R Didziapetris et al.
JOURNAL OF DRUG TARGETING (2003)
Drugs as P-glycoprotein substrates, inhibitors, and inducers
RB Kim
DRUG METABOLISM REVIEWS (2002)
Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors
EJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
JC-1: a very sensitive fluorescent probe to test Pgp activity in adult acute myeloid leukemia
O Legrand et al.
BLOOD (2001)
Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction
A Eneroth et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2001)
Share Paper
